ASX:CSL CSL (CSL) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About CSL Stock (ASX:CSL) 30 days 90 days 365 days Advanced Chart Get CSL alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume869,289 shsAverage VolumeN/AMarket CapitalizationA$77.43 billionP/E Ratio28.02Dividend Yield1.56%Price TargetN/AConsensus RatingN/A Company Overview CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia. Read More Receive CSL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CSL and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CSL Stock News HeadlinesThis leading broker thinks the CSL share price can climb 40%August 27 at 10:13 PM | msn.comCSL Limited Announces Director’s Interest ChangeAugust 27 at 2:30 AM | tipranks.comTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.August 28 at 2:00 AM | Porter & Company (Ad)BMW M3 CSL E46 vs VW Bora VR6 – 1/4 Mile RaceAugust 27 at 2:24 AM | msn.comThe CSL share price is at a 6-year low. Should you buy?August 26 at 8:23 PM | msn.comAsk the analyst: Are markets missing something with CSL?August 26 at 8:23 PM | morningstar.com.auMCSL veteran says Victoria’s WFH culture led to lab failuresAugust 26 at 8:23 PM | afr.comForecast: Here's what $20,000 invested in CSL shares could be worth by 2030August 25 at 2:06 AM | msn.comSee More Headlines CSL Stock Analysis - Frequently Asked Questions How were CSL's earnings last quarter? CSL Limited (ASX:CSL) announced its quarterly earnings data on Wednesday, August, 14th. The company reported $4.24 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $4.22 by $0.01. CSL had a net margin of 18.41% and a trailing twelve-month return on equity of 15.37%. What other stocks do shareholders of CSL own? Based on aggregate information from My MarketBeat watchlists, some other companies that CSL investors own include Cochlear (COH), Mineral Resources (MIN), ResMed (RMD), Magellan Financial Group (MFG), NIB (NHF), Accent Group (AX1) and Corporate Travel Management (CTD). Company Calendar Last Earnings8/14/2019Today8/28/2025Ex-Dividend for 10/2 Dividend9/08/2025Record date for 10/2 Dividend10/02/2025Dividend Payable10/02/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryRubber And Plastic Products Current SymbolASX:CSL CIKN/A Webwww.csl.com.au Phone+61-3-93891911FaxN/AEmployees12,500Year FoundedN/AProfitability EPS (Trailing Twelve Months)A$7.88 Trailing P/E Ratio28.02 Forward P/E RatioN/A P/E Growth1.29Net IncomeA$2.64 billion Net Margins18.41% Pretax MarginN/A Return on Equity15.37% Return on Assets6.56% Debt Debt-to-Equity Ratio64.46 Current Ratio1.86 Quick Ratio1.68 Sales & Book Value Annual SalesA$14.80 billion Price / Sales0.00 Cash FlowN/A Price / Cash Flow207.70 Book ValueA$42.52 per share Price / BookN/AMiscellaneous Outstanding Shares484,210,000Free FloatN/AMarket CapA$77.43 billion OptionableNot Optionable Beta0.32 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report This page (ASX:CSL) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredTrump's "Big Beautiful Bill" hides ugly truthWashington’s new “Big Beautiful Bill” promises tax breaks… but the fine print tells a different story: trillio...Defi Master | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CSL Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share CSL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.